Medico Remedies Limited has informed the Exchange regarding Appointment of Ms Shreya Shah as Other of the company w.e.f. July 30, 2025.
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medico Remedies' Board, at its July 30, 2025 meeting, approved several leadership changes. Mr. Harshit Mehta was re-appointed as Managing Director for another 3 years (Sept 17, 2025 to Sept 17, 2028), subject to shareholder approval. Mr. Haresh Mehta, the founding member and Chairman & Whole-Time Director with 45+ years of pharma experience, will continue as a director even after turning 70 on August 17, 2025, again pending shareholder nod. Mr. Maheshkumar Darji, currently General Manager – Plant with 20+ years of pharma experience, was appointed as Additional Executive Director. The Secretarial Auditor, Mr. Haresh Sanghvi, resigned mid-term citing medical grounds, and Ms. Shreya Shah (a practicing Company Secretary with 10+ years of experience) was appointed as the new Secretarial Auditor for a 5-year term (FY26–FY30). Notice of the 31st AGM was also issued.
Leadership continuity with the promoter Mehta family firmly in control — no change in strategic direction expected. The secretarial auditor change is health-driven, not governance-related, so it should not concern investors. Stock impact likely neutral.